Skip to Main Content

Paper Details

Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
Pharmacoepidemiol Drug Saf
5
2022
Author NameAffiliation
Jennifer E FlytheUniversity of North Carolina Kidney Center, UNC School of Medicine
Jennifer E FlytheCecil G. Sheps Center for Health Services Research, University of North Carolina
  • 1 - 2

Datasets

Release 1.2